Altman to VCs: no $1T OpenAI exit in 2026, IPO waits

For founders and venture investors, the message is blunt: the most valuable private company in AI is telling its backers to wait. Altman says OpenAI feels no pressure to go public, which means secondary-market appetite, 409A valuations, and employee retention incentives stay private-market problems for at least four more quarters. Every AI startup contemplating a 2026 IPO now has to decide whether to follow the leader or seize the open window.

Sam Altman has officially removed the most anticipated technology listing from the 2026 IPO calendar. In a Fortune interview published Saturday, September 12, 2026, the OpenAI chief executive said the company will not go public this year, citing the intensifying crisis over artificial intelligence safety. "I actually think that, given everything happening with safety, right now would be an ill-advised moment to go public, and we don't feel pressure on that," Altman said. Asked directly whether 2026 is off the table in favor of 2027, he answered flatly: "I would say not 2026." The confirmation follows a June 2026 New York Times report that the San Francisco-based company was weighing whether to hold off on a potentially trillion-dollar IPO until next year. That deliberation coincided with a rough stretch for the most recent mega-listing benchmark: shares in Elon Musk's SpaceX were tumbling after a surge pushed that company's valuation to $1.8 trillion. Altman's remarks now convert market speculation into corporate policy.

“

That deliberation coincided with a rough stretch for the most recent mega-listing benchmark: shares in Elon Musk's SpaceX were tumbling after a surge pushed that company's valuation to $1.8 trillion.

The proximate cause is safety. The weeks preceding the interview saw dire warnings from two researchers at Anthropic, OpenAI's chief rival, that rapidly progressing artificial intelligence could lead to the extinction of the human race "in the not-too-distant future." Those warnings arrived amid reports of AI agents going rogue to hack external systems, and of AI safety researchers quitting their companies over concerns about the technology's risks. Politicians from both parties responded with alarm, and a growing number of US lawmakers are now calling for new rules to govern AI systems. For OpenAI, the optics of conducting a public offering during a debate about existential risk were untenable; a company whose product could plausibly be framed as an extinction-level liability would face brutal S-1 risk-factor drafting, investor education hurdles, and immediate securities litigation exposure after any post-listing incident.

For investors, the delay extends illiquidity. Late-stage backers and employees holding private shares now face a longer horizon before a public exit, even as secondary-market appetite for AI equity remains strong. Altman was explicit that OpenAI feels no pressure on the listing, which gives leadership the latitude to prioritize what he called "meeting this moment of what is going to be required for safety and alignment, and how the industry and governments can work together." That posture is far easier to sustain as a private company without quarterly disclosure obligations, board risk-committee mandates, and the public scrutiny of a listed name. The absence of OpenAI from the 2026 calendar also reshapes the tech IPO narrative: the blockbuster debut investors hoped would anchor a new AI era now looks like a 2027 event at the earliest. With SpaceX's $1.8 trillion valuation wobbling in the weeks after its own listing, underwriters and late-stage investors lose their strongest comparable for a new generation of tech IPOs.